Chemokine regulation of inflammation during respiratory syncytial virus infection

Rinat Nuriev1,2, Cecilia Johansson1

  • 1National Heart and Lung Institute, Imperial College London, London, UK.

F1000Research
|November 15, 2019
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe lung infections, particularly in vulnerable groups. This review explores how chemokines regulate immune responses and inflammation during RSV infection.

Area of Science:

  • Immunology
  • Virology
  • Respiratory Medicine

Background:

  • Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and infant hospitalizations globally.
  • Immune responses are vital for controlling RSV but can lead to immunopathology if dysregulated.
  • Lung immunity initiation involves immune cell recruitment to the lungs.

Purpose of the Study:

  • To review recent advances in understanding RSV infection and disease.
  • To focus on the role of chemokines in regulating virus-induced inflammation in the lungs.

Main Methods:

  • Literature review of recent advances in RSV research.
  • Focus on the mechanisms of chemokine-mediated immune cell recruitment.

Main Results:

  • Chemokines are key regulators of inflammation during RSV infection.
  • Chemokines orchestrate the recruitment of various leukocytes to the lungs.
  • Dysregulated chemokine activity can contribute to RSV-associated immunopathology.

Conclusions:

  • Understanding chemokine function is crucial for managing RSV-induced lung inflammation.
  • Targeting chemokines may offer therapeutic strategies for severe RSV disease.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
972
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K